Surgeon Howard N. Langstein joins the company to leverage his experience and help other surgeons optimize clinical outcomes in plastic & reconstructive surgery.
Data affirm the algorithm is effective at identifying patterns and classifying AF episodes into medically relevant events that require clinical action.
Collaboration with CardioNXT provides navigation and mapping system integration with Pulse Biosciences’ nsPFA circumferential catheter to support treatments.
New member is chief medical officer and VP of Clinical Affairs, Technology, and Innovation of the Peripheral Interventions division at Boston Scientific.